BRPI0906248A2 - composto, composição farmacêutica para inibir a formação de microtúbulos e método para preparar um composto - Google Patents
composto, composição farmacêutica para inibir a formação de microtúbulos e método para preparar um compostoInfo
- Publication number
- BRPI0906248A2 BRPI0906248A2 BRPI0906248A BRPI0906248A BRPI0906248A2 BR PI0906248 A2 BRPI0906248 A2 BR PI0906248A2 BR PI0906248 A BRPI0906248 A BR PI0906248A BR PI0906248 A BRPI0906248 A BR PI0906248A BR PI0906248 A2 BRPI0906248 A2 BR PI0906248A2
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- preparing
- pharmaceutical composition
- microtubule formation
- inhibiting microtubule
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 2
- 102000029749 Microtubule Human genes 0.000 title 1
- 108091022875 Microtubule Proteins 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
- 210000004688 microtubule Anatomy 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Virology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20080027820 | 2008-03-26 | ||
| PCT/KR2009/001095 WO2009119980A2 (ko) | 2008-03-26 | 2009-03-05 | 미세소관 형성 저해제로서 유용한 벤조페논 티아졸 유도체 및 이의 제조 방법 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BRPI0906248A2 true BRPI0906248A2 (pt) | 2016-10-25 |
| BRPI0906248B1 BRPI0906248B1 (pt) | 2020-01-21 |
| BRPI0906248B8 BRPI0906248B8 (pt) | 2021-05-25 |
Family
ID=41114435
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0906248A BRPI0906248B8 (pt) | 2008-03-26 | 2009-03-05 | composto, composição farmacêutica para inibir a formação de microtúbulos e método para preparar um composto |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8362267B2 (pt) |
| EP (1) | EP2272845B1 (pt) |
| JP (1) | JP5378499B2 (pt) |
| KR (1) | KR101069735B1 (pt) |
| CN (1) | CN101981029B (pt) |
| AU (1) | AU2009229709B2 (pt) |
| BR (1) | BRPI0906248B8 (pt) |
| CA (1) | CA2719243C (pt) |
| DK (1) | DK2272845T3 (pt) |
| ES (1) | ES2536794T3 (pt) |
| HU (1) | HUE025268T2 (pt) |
| MX (1) | MX2010010561A (pt) |
| PL (1) | PL2272845T3 (pt) |
| PT (1) | PT2272845E (pt) |
| WO (1) | WO2009119980A2 (pt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2019517506A (ja) * | 2016-07-29 | 2019-06-24 | チョン クン ダン ファーマシューティカル コーポレーション | 血管破壊剤を含む肝臓癌治療用の組成物 |
| US9980953B2 (en) * | 2016-09-26 | 2018-05-29 | Chong Kun Dang Pharmaceutical Corp. | Combined composition for preventing or treating cancer comprising a benzophenone thiazole derivatives as a VDA and topoisomerase inhibitor |
| CN107163011B (zh) * | 2017-05-27 | 2019-10-01 | 上海应用技术大学 | 3-(3,4,5-三甲氧基苯甲酰)-苯并呋喃类微管蛋白抑制剂及其制备方法和用途 |
| JP6956254B2 (ja) * | 2017-07-26 | 2021-11-02 | チョン クン ダン ファーマシューティカル コーポレーション | 血管遮断剤および免疫チェックポイント阻害剤を含む癌の予防または治療用の組成物 |
| KR102216772B1 (ko) | 2018-05-18 | 2021-02-17 | 주식회사 종근당 | 혈관차단제 및 탁산 화합물을 포함하는 암 예방 또는 치료용 조성물 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA05009434A (es) | 2003-03-05 | 2005-11-23 | Celgene Corp | Compuestos de difeniletileno y usos de los mismos. |
| RU2396250C2 (ru) * | 2003-07-24 | 2010-08-10 | Лео Фарма А/С | Новые производные аминобензофенона |
| EP1828148B1 (en) | 2004-12-13 | 2010-01-20 | Leo Pharma A/S | Triazole substituted aminobenzophenone compounds |
| KR100932093B1 (ko) * | 2006-09-27 | 2009-12-16 | 주식회사종근당 | 미세소관 형성 저해제로서 유용한 벤조페논 유도체 |
-
2009
- 2009-03-05 PL PL09725663T patent/PL2272845T3/pl unknown
- 2009-03-05 US US12/934,521 patent/US8362267B2/en active Active
- 2009-03-05 HU HUE09725663A patent/HUE025268T2/en unknown
- 2009-03-05 MX MX2010010561A patent/MX2010010561A/es active IP Right Grant
- 2009-03-05 DK DK09725663.0T patent/DK2272845T3/en active
- 2009-03-05 JP JP2011501712A patent/JP5378499B2/ja active Active
- 2009-03-05 PT PT97256630T patent/PT2272845E/pt unknown
- 2009-03-05 EP EP09725663.0A patent/EP2272845B1/en active Active
- 2009-03-05 CN CN200980110763.9A patent/CN101981029B/zh active Active
- 2009-03-05 BR BRPI0906248A patent/BRPI0906248B8/pt active IP Right Grant
- 2009-03-05 WO PCT/KR2009/001095 patent/WO2009119980A2/ko not_active Ceased
- 2009-03-05 ES ES09725663.0T patent/ES2536794T3/es active Active
- 2009-03-05 KR KR1020090018700A patent/KR101069735B1/ko active Active
- 2009-03-05 CA CA2719243A patent/CA2719243C/en active Active
- 2009-03-05 AU AU2009229709A patent/AU2009229709B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US8362267B2 (en) | 2013-01-29 |
| PL2272845T3 (pl) | 2015-08-31 |
| BRPI0906248B8 (pt) | 2021-05-25 |
| CA2719243C (en) | 2013-06-25 |
| KR101069735B1 (ko) | 2011-10-04 |
| EP2272845B1 (en) | 2015-03-04 |
| DK2272845T3 (en) | 2015-05-04 |
| PT2272845E (pt) | 2015-06-01 |
| JP5378499B2 (ja) | 2013-12-25 |
| AU2009229709A1 (en) | 2009-10-01 |
| CN101981029A (zh) | 2011-02-23 |
| HUE025268T2 (en) | 2016-02-29 |
| CN101981029B (zh) | 2014-04-02 |
| WO2009119980A2 (ko) | 2009-10-01 |
| EP2272845A2 (en) | 2011-01-12 |
| MX2010010561A (es) | 2010-10-25 |
| BRPI0906248B1 (pt) | 2020-01-21 |
| WO2009119980A3 (ko) | 2009-12-17 |
| US20110021582A1 (en) | 2011-01-27 |
| AU2009229709B2 (en) | 2011-12-08 |
| CA2719243A1 (en) | 2009-10-01 |
| JP2011515461A (ja) | 2011-05-19 |
| KR20090102639A (ko) | 2009-09-30 |
| ES2536794T3 (es) | 2015-05-28 |
| EP2272845A4 (en) | 2014-01-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0909691A2 (pt) | Composto, método para preparar um composto, e, composição farmacêutica | |
| BRPI0906906A2 (pt) | Método para preparar um composto e composto | |
| BR112012000968A2 (pt) | composto, composição e método para inibir uma fosfatidil inositol-3 cinase. | |
| BRPI0917196A2 (pt) | método para a preparação de um complexo, e, forma cristalina de um composto. | |
| BRPI0818533A2 (pt) | composto, composição farmacêutica, e, processo para a preparação de um composto | |
| BRPI0922475A2 (pt) | composto, composição farmacêutica , método para tratar câncer, e, uso de um composto. | |
| BRPI0922566A2 (pt) | polimorfo cristalino, composição farmacêutica, composto, e, métodos para preparar um composto, e para tratar uma doença. | |
| BRPI1011592A2 (pt) | "composição, e, método para fazer manutenção em um furo de poço." | |
| BRPI0819568A2 (pt) | métodos para a preparação de um composto | |
| BRPI0814153A2 (pt) | "método para preparar um composto e composto" | |
| BRPI0906475A2 (pt) | Compostos, processso para a preparação de um composto, composição farmacêutica e uso de um composto | |
| BRPI0918038A2 (pt) | Processos para preparar um composto e um sal, e, composto | |
| BRPI0910734A2 (pt) | composto, composição farmacêutica, e, processo para preparar um composto ou um sal farmaceuticamente aceitável do mesmo. | |
| BRPI0812999A2 (pt) | Método para preparar um composto | |
| BRPI0912384A2 (pt) | composição, e, método para preparar uma composição | |
| BR112014007645A2 (pt) | composto heterocíclico, métodos para a preparação de um composto heterocíclico, e, composição farmacêutica | |
| BRPI0914918A2 (pt) | forma de dosagem farmacêutica, e, método para preparar uma forma de dosagem sólida. | |
| BR112012000623A2 (pt) | composição de emulsão estabilizada, método, e, método para preparar uma composição de emulsão estabilizada | |
| BRPI1016132A2 (pt) | composição, formulação farmacêutica, método para fabricar uma formulação farmacêutica estável. | |
| BR112013008008A2 (pt) | composto, composição farmacêutica e processo para preparar um composto | |
| BRPI1011888A2 (pt) | processo para preparar um composto, e, composição. | |
| BRPI0909198A2 (pt) | composto antifolato, composto, método para preparar um composto antifolato, composição farmacêutica, método para tratar | |
| BRPI0816331A2 (pt) | Composto, uso de um composto, composição farmacêutica, e, processo para preparar um composto. | |
| BRPI1012978A2 (pt) | composição tópica, método para preparar a mesma, e, uso de um composto | |
| BRPI1015983A2 (pt) | composto, uso do composto, método para tratar um paciente, e, composição farmacêutica. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25D | Requested change of name of applicant approved |
Owner name: CHONG KUN DANG HOLDINGS CORP. (KR) |
|
| B25A | Requested transfer of rights approved |
Owner name: CHONG KUN DANG PHARMACEUTICAL CORP. (KR) |
|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 21/01/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 05/03/2009 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |